|
Stay up-to-date with the latest O&T News in Europe
Read EFORT's official Newsletter with a round up of all EFORT activities
|
|
|
|
|
|
|
High-quality instructional peer-reviewed articles
across the whole field of Orthopaedics and Traumatology
|
|
|
|
|
|
|
Save the date for the upcoming EFORT Webinar
|
On Monday 29 January 2024 at 19:00 CET, the EFORT Webinar on Limits of The Masquelet Technique in Segmental Bone Defects will focus on the management of “critical size” bone defects. This event will be chaired by Thierry Bégué, France.
The objectives of this webinar are:
- To identify what is a “critical size” bone defects;
- To assess bone defect area for evaluation of bone and soft tissue;
- To learn about the healing process and pitfalls with the different techniques of bone reconstruction.
|
This Webinar is organised by EFORT independent of any commercial educational support.
|
|
|
|
|
|
|
A commitment to work at improving diversity, equity and inclusion in O& T
|
Since the launch of the IODA Charter in 2022, twenty organisations worldwide have signed the Charter – half of which are European.
This engagement is encouraging, but what does it mean to sign the IODA Charter? It is a public commitment to work at improving diversity, equity and inclusion (DEI) in the specialty; and from feedback IODA has received thus far, an incentive to carry out the important work required to achieve these great objectives.
The IODA Charter highlights action points that can assist your organisation or society focus and initiate objectives to drive culture change based on the identified barriers. These action points can be implemented into local strategic plans and policies —see road map below. IODA is excited to see outlined DEI metrics improve over time from this important work all around the world.
|
|
|
|
|
|
|
IT tools for regulatory science
|
|
|
|
|
|
|
This webinar aimed to:
- To discover the activities performed during the CORE-MD project in support to automated data aggregation of safety notices for post-market surveillance.
- To understand EMA Expert Panel’s roles in post-market surveillance and vigilance.
- To receive regulator’s perspective on the use of real-world evidence.
|
CORE-MD is a European Union Horizon 2020 project. It reviews methods for evaluating high-risk medical devices in order to translate expert evidence into advice for EU regulators and to recommend an appropriate balance between innovation, safety , and clinical effectiveness.
|
|
|
|
|
|
|
A quick access to prime educational material
|
|
|
|
|
|
